VERSATILE
LIVE

Serial Number

97483940

Owner

Pillar Biosciences, Inc.

Attorney

Andrew T. Pettit

Filing Date

Jun 30, 2022

Add to watchlist:

No watchlists yet
View on USPTO

VERSATILE Trademark

Serial Number: 97483940

VERSATILE is a trademark filed by Pillar Biosciences, Inc. on June 30, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Pillar Biosciences, Inc. (17 trademarks)

Natick, MA 01760

Entity Type: 03

Trademark Details

Filing Date

June 30, 2022

Registration Date

Not Registered

Published for Opposition

April 18, 2023

Goods & Services

Software as a service (SaaS), namely, hosting non-downloadable software for use by others for discovering combinations of primers for achieving a reaction of interest; software as a service (SaaS), namely, hosting non-downloadable software for use by others for simulating biological, chemical, and biochemical reactions through the use of artificial intelligence or machine learning; software as a service (SaaS), namely, hosting non-downloadable software for use by others for discovering tiling solutions for achieving a reaction of interest, each tiling solution being representative of a different combination of primers, and then determining the optimal tiling solution for achieving the reaction of interest; software as a service (SaaS), namely, hosting non-downloadable software for use by others for determining chemistry through the use of artificial intelligence or machine learning; software as a service (SaaS), namely, hosting non-downloadable software for use by others for designing primer pools for reactions without the need for laboratory testing; software as a service (SaaS), namely, hosting non-downloadable software for use by others for simulating interactions involving nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, diagnostic research, and diagnostics; software as a service (SaaS), namely, hosting non-downloadable software for use by others for bioinformatics; software as a service (SaaS), namely, hosting non-downloadable software for use by others for health and wellness assessment, namely, for use in genomic analysis; software as a service (SaaS), namely, hosting non-downloadable software for use by others for genetic and bioinformatics analysis; software as a service (SaaS), namely, hosting non-downloadable software for use by others for testing deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) molecules for research purposes; bioinformatics services, namely, product research and development in the field of bioinformatics; developing artificial intelligence algorithms and machine learning algorithms for medical, clinical, and scientific purposes; developing artificial intelligence algorithms and machine learning algorithms for use by others to develop products related to the diagnosis, management, or treatment of disease; consulting relating to research and development of products related to the diagnosis, management, or treatment of disease; providing a service for designing primers on behalf of others; providing a service for designing primers on behalf of healthcare entities, including hospital systems, pharmaceutical companies, and researchers

Downloadable software for discovering combinations of primers for achieving a reaction of interest; downloadable software for determining the optimal combination of primers for achieving a reaction of interest; downloadable software for simulating biological, chemical, and biochemical reactions through the use of artificial intelligence or machine learning; downloadable software that discovers tiling solutions for achieving a reaction of interest, each tiling solution being representative of a different combination of primers, and then determines the optimal tiling solution for achieving the reaction of interest; downloadable software for determining chemistry through the use of artificial intelligence or machine learning; downloadable software for designing primer pools for reactions without the need for laboratory testing; downloadable software for simulating interactions involving nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, diagnostic research, and diagnostics; downloadable software for bioinformatics; downloadable software for health and wellness assessment, namely, for use in genomic analysis; downloadable software for genetic and bioinformatics analysis; downloadable software for testing deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) molecules for research purposes; downloadable software for testing DNA and RNA molecules for diagnostic purposes; downloadable software for use in the fields of nucleic acid sequencing, genotyping, scientific research, clinical research, diagnostics research, and diagnostics; downloadable software for determining the optimal combination of primers for achieving a reaction of interest; downloadable software for testing DNA and RNA molecules for diagnostic purposes; downloadable software for use in the fields of nucleic acid sequencing, genotyping, scientific research, clinical research, diagnostics research, and diagnostics; downloadable software for determining the optimal combination of primers for achieving a reaction of interest; downloadable software for testing DNA and RNA molecules for diagnostic purposes; downloadable software, namely, software for discovering combinations of primers through simulation of reactions, for use in the fields of nucleic acid sequencing, genotyping, scientific research, clinical research, diagnostics research, and diagnostics

Data processing services for medical, clinical, and scientific purposes; data processing services, namely, analysis of data related to primers to identify those primers that are able to induce a reaction of interest; data processing services, namely, analysis of data related to nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, diagnostic research, and diagnostics; data processing services for medical, clinical, and scientific purposes

Filing History

SOU TEAS EXTENSION RECEIVED
Dec 10, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 16, 2025 EXRA
SOU EXTENSION 4 GRANTED
May 16, 2025 EX4G
SOU EXTENSION 4 FILED
May 15, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
May 15, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 3 GRANTED
Dec 3, 2024 EX3G
SOU EXTENSION 3 FILED
Dec 3, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 3, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 12, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jun 12, 2024 EX2G
SOU EXTENSION 2 FILED
Jun 12, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 12, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 14, 2023 EXRA
SOU EXTENSION 1 GRANTED
Dec 12, 2023 EX1G
SOU EXTENSION 1 FILED
Dec 12, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 12, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 13, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 18, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 18, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 29, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 10, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 10, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 10, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 10, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 10, 2023 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 26, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 26, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 26, 2022 CNRT
EXAMINER'S AMENDMENT ENTERED
Oct 26, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 26, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 26, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 26, 2022 CNEA
ASSIGNED TO EXAMINER
Oct 26, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 6, 2022 NWOS
NEW APPLICATION ENTERED
Jul 4, 2022 NWAP